About Probiont
Probiont is a company based in Helsinki (Finland) founded in 2021. It operates as a B2B. Probiont offers products and services including Organ-on-a-Chip Technology. Probiont operates in a competitive market with competitors including CytoSite Bio, Isabl, NovelStem, AccuTheranostics and Precision Therapeutics, among others.
- Headquarter Helsinki, Finland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Probiont Oy
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$33.95 K (USD), Grant
Nov 01, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Probiont
Probiont offers a comprehensive portfolio of products and services, including Organ-on-a-Chip Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for rapid screening of cancer immunotherapy drugs on patient models
Funding Insights of Probiont
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $33,952
-
First Round
First Round
(01 Nov 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Grant - Probiont | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Probiont
Probiont has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Probiont
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Probiont
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Probiont Comparisons
Competitors of Probiont
Probiont operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CytoSite Bio, Isabl, NovelStem, AccuTheranostics and Precision Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Precision imaging products for immuno-oncology therapy are developed.
|
|
| domain | founded_year | HQ Location |
Cancer patients' genomes are analyzed by a medical diagnosis platform.
|
|
| domain | founded_year | HQ Location |
Stem cell diagnostics for predicting cancer chemotherapy resistance are developed.
|
|
| domain | founded_year | HQ Location |
Personalized chemotherapy response testing is offered for cancer patients.
|
|
| domain | founded_year | HQ Location |
Precision Therapeutics develops a platform for innovative, personalized cancer therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Probiont
When was Probiont founded?
Probiont was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Probiont located?
Probiont is headquartered in Helsinki, Finland.
What does Probiont do?
Probiont focuses on creating personalized solutions for testing the efficacy of cancer immunotherapy. They utilize organ-on-a-chip technology to replicate patient-specific physiological functions, enabling rapid screening of drugs and early identification of effective treatments. This approach supports diagnostics and drug development in oncology. The company is based in Helsinki, Finland, aiming to provide cost-effective tools for targeted therapies without specifying client details.
Who are the top competitors of Probiont?
Probiont's top competitors include CytoSite Bio, NovelStem and Isabl.
What products or services does Probiont offer?
Probiont offers Organ-on-a-Chip Technology.
Who are Probiont's investors?
Probiont has 1 investor. Key investors include European Union.